Search by keywords: and/or Explore by tags: Cancer CareCancer Care › Clinical TrialsCancer Care › DiagnosisCancer Care › Diagnosis › PathologyCancer Care › Genetic TestingCancer Care › Integrative MedicineCancer Care › Integrative Medicine › AcupunctureCancer Care › Medical TechnologyCancer Care › Medical Technology › Bone ScanCancer Care › Medical Technology › CTCancer Care › Medical Technology › MRICancer Care › NursingCancer Care › Pain ManagementCancer Care › Palliative CareCancer Care › Patient Care FacilitiesCancer Care › Prediction ToolsCancer Care › PreventionCancer Care › ScreeningCancer Care › Screening › ColonoscopyCancer Care › Screening › MammographyCancer Care › Screening › PSA TestingCancer Care › TreatmentCancer Care › Treatment › Blood & Marrow Stem Cell TransplantationCancer Care › Treatment › Plastic & Reconstructive SurgeryCancer Care › Treatment › Interventional Radiology Cancer Care › Treatment › Robotic SurgeryCancer Care › Treatment › ChemotherapyCancer Care › Treatment › Gene TherapyCancer Care › Treatment › Hormone TherapyCancer Care › Treatment › ImmunotherapyCancer Care › Treatment › Personalized MedicineCancer Care › Treatment › Radiation TherapyCancer Care › Treatment › SurgeryCancer Care › Treatment › Targeted TherapyCounseling & SupportCounseling & Support › CancerSmartCounseling & Support › Cognitive TestingCounseling & Support › PsychiatryCounseling & Support › Sexual HealthCounseling & Support › Social WorkCounseling & Support › Virtual ProgramsEducation & TrainingMiscellaneousMiscellaneous › FacebookMiscellaneous › WebsiteSurvivorshipSurvivorship › BridgesResearchResearch › Cancer Genetics & GenomicsResearch › Sloan Kettering InstituteResearch › Cancer Immunotherapy & VaccinesResearch › Cancer MetabolismResearch › CellBased TherapyResearch › Cell Signaling & RegulationResearch › Chemical BiologyResearch › Computational OncologyResearch › Developmental BiologyResearch › Discoveries & AdvancesResearch › Discoveries & Advances › Lab ResearchResearch › Discoveries & Advances › Clinical ResearchResearch › Discoveries & Advances › Health Outcomes, Epidemiology & StatisticsResearch › EpigeneticsResearch › Genome IntegrityResearch › Hematologic MalignanciesResearch › ImagingResearch › ImmunologyResearch › Metastasis & Drug ResistanceResearch › Microbiome & InflammationResearch › Molecular Pathology & DiagnosticsResearch › NanotechnologyResearch › Neuroscience & NeuroOncologyResearch › Solid Tumor OncogenesisResearch › Stem Cell BiologyResearch › Structural BiologyResearch › Systems BiologyResearch › Targeted TherapyResearch › Tumor MicroenvironmentGivingGiving › Donating BloodGiving › FundraisingGiving › The Society of MSKCCGiving › Volunteering Connect with us Sloan Kettering @GSKGradSchool Tweets by @GSKGradSchool 16 News Items found In the Lab Novel Tool Enables Study of Rare Acute Myeloid Leukemia Stem Cells Monday, April 27, 2020 MSK investigators have used a lab tool originally developed to study fly nerve cells to uncover new findings about acute myeloid leukemia. Feature Researchers Find that Vitamin B6 Contributes to Survival of Acute Myeloid Leukemia Cells Monday, January 13, 2020 This research marks the first time researchers have found a connection between vitamin B6 and cancer. In the Lab Researchers Identify a Bacterial Species That Could Protect against Hospital-Acquired Infections Wednesday, August 21, 2019 MSK researchers are reporting that a bacterial species called Blautia producta appears to release a substance that kills harmful bacteria. In the Lab Ro Versus Musashi: How One Molecule Can Turn Cancer Cells Back to Normal Wednesday, June 19, 2019 Researchers identify a compound that appears to eliminate tumor cells in a dish and in mice. In the Lab Something New Under the Sun: Study in Leukemia Finds Role for Helios Protein Wednesday, November 21, 2018 MSK researchers have found that a protein that contributes to one type of leukemia when it’s missing can lead to the formation of a different leukemia type when it’s present. Announcement FDA Approves Enasidenib (Idhifa), a First-of-Its-Kind Drug, for Advanced Blood Cancer Wednesday, August 2, 2017 A new treatment option for people with acute myeloid leukemia is available, and it works in an unconventional way. In the Lab Step by Step: Stem Cell Approach Provides New Models for Studying How Acute Myeloid Leukemia Progresses Monday, February 20, 2017 A new laboratory tool will allow researchers to study the progression from normal cells to myelodysplastic syndromes to an aggressive type of leukemia. In the Clinic The Evolution of a Lifesaving Drug: A Scientist Reflects Thursday, March 12, 2015 Physician-scientist Charles Sawyers played a pivotal role in the development of Gleevec, one of the first successful targeted drugs for cancer. Decoder What Is Epigenetics? Tuesday, October 14, 2014 Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer. In the Lab Compound from Tropical Plant Targets Key Cancer-Causing Genes Monday, July 28, 2014 Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting <em>MYC</em>, a cancer-causing gene that has remained elusive until now. In the Clinic New Trial Advances Cell-Based Immune Therapy for Certain Leukemias Thursday, February 20, 2014 A new study evaluating a cell-based immune therapy to treat an aggressive type of leukemia — the largest study of its kind to date — reports that 88 percent of patients responded to the treatment. In the News New Biotech Startup Will Pit the Immune System Against Cancer Friday, December 6, 2013 Memorial Sloan Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines. In the Clinic Cell-Based Immune Therapy Shows Promise in Leukemia Patients Wednesday, March 20, 2013 Memorial Sloan Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia. In the Lab New Molecule Targets Proteins Inside Cancer Cells Wednesday, March 13, 2013 Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells. In the Lab Researchers Discover Why Some Leukemia Drugs Are Not Sufficiently Effective Thursday, September 6, 2012 Memorial Sloan Kettering researchers have found why certain drugs are not sufficiently effective in treating leukemias called myeloproliferative neoplasms. Profile Genetic Causes of Blood Cancers Explored Thursday, December 1, 2011 German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.